Skip to main content
Signal8

Makhzoumi Mohamad

SEC insider (Form 3/4/5 filer). CIK 0001630226. 10% Owner at Korro Bio, Inc. (KRRO) and 4 other issuers. 45 reported Form 4/5 transactions since Sep 2024; latest on Mar 10, 2026. Located in MENLO PARK, CA.

Companies Makhzoumi Mohamad has filed insider reports for

  • Korro Bio, Inc. (KRRO): 10% Owner
  • Trevi Therapeutics, Inc. (TRVI): 10% Owner
  • SpyGlass Pharma, Inc. (SGP): 10% Owner
  • NeueHealth, Inc. (NEUE): Director, 10% Owner
  • MBX Biosciences, Inc. (MBX): 10% Owner
Makhzoumi Mohamad profile photo

Makhzoumi Mohamad

CIK: 0001630226

Transaction Breakdown

Open Market Buys (P)3 (6.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)10 (22.2%)

Derivative conversions

Awards (A)8 (17.8%)

Compensation grants

Other (G, F, J, C, D, …)24 (53.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

Korro Bio, Inc. logo
KRRO

Korro Bio, Inc.

10% Owner
Trevi Therapeutics, Inc. logo
TRVI

Trevi Therapeutics, Inc.

10% Owner
SpyGlass Pharma, Inc. logo
SGP

SpyGlass Pharma, Inc.

10% Owner
NeueHealth, Inc. logo
NEUE

NeueHealth, Inc.

Director10% Owner
MBX Biosciences, Inc. logo
MBX

MBX Biosciences, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (45 total)

  • Korro Bio, Inc. logo
    KRRO

    Korro Bio, Inc.

    Mar 10, 2026
    Purchase
    Indirect
    207.1K shares at avg. $11.11$2.3M
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    1.4M shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    1.4M shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    738K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    955K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    402.3K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Purchase
    Indirect
    937.5K shares at avg. $16.00$15.0M
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    1.6M shares-
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Exercise
    Indirect
    189.2K shares at avg. $0.01$2K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Disposition
    Indirect
    43.7K shares-

1-10 of 45